Analyzing Minerva Surgical (NASDAQ:UTRS) and Hypertension Diagnostics (OTCMKTS:HDII) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
MASON, Ohio, January 25, 2024 AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024.
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management and post-operative pain management, today announced it appointed.
AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation , left atrial appendage management, and post-operative pain management, today announced that the company will be.